Methods for affecting body composition

Details Methods for affecting body composition Methods for affecting body composition

2008-07-15

2008-07-15

Tsang, Cecilia (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

10851574

ABSTRACT:
Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.

REFERENCES:
patent: 5264372 (1993-11-01), Beaumont et al.
patent: 5580953 (1996-12-01), Albrecht et al.
patent: 5677279 (1997-10-01), Young
patent: 5686411 (1997-11-01), Gaeta et al.
patent: 5739106 (1998-04-01), Rink et al.
patent: 5998367 (1999-12-01), Gaeta et al.
patent: 6114304 (2000-09-01), Kolterman et al.
patent: 6410511 (2002-06-01), L'Italien et al.
patent: 6610824 (2003-08-01), Gaeta et al.
patent: 2003/0026812 (2003-02-01), Duft et al.
patent: 2003/0092606 (2003-05-01), L'Italien et al.
patent: 2004/0022807 (2004-02-01), Duft et al.
patent: 0 289 287 (1998-01-01), None
patent: WO 98/50059 (1998-11-01), None
Bray, George, “Drug treatment of obesity”, Am J. Clin Nutr 1992; 55:538S-44S.
Eiden, S., et al., “Calcitonin—a potent inhibitor of food intake in states of impaired leptin signalling in laboratory rodents”, J. Physiol. 2002; 541(Pt):1041-1048.
Jung, Roland T., et al., “The management of obesity”, Clinical Endocrinology 1991; 35:11-20.
Kuestner, Rolf E., “Cloning and Characterization of an Abundant Subtype of the Human Calcitonin Receptor,” Mol Pharma 1994; 46:246-255.
Lee, Yann-Jinn, et al., Successful Weight Loss with Protein-Sparing Modified Fast in a Morbidly Obese Boy with . . . Clinical Pediatrics Apr. 1992; 234-236.
Lutz, T.A., et al.,“Repeated salmon calcitonin injection lowers body weight ad body fat.” Scientific World Journal Dec. 18, 2001; 1(12 Sup 1):25.
Mack, C., et al., “Sustained reduction in food intake and body weight in high fat-fed rats during 28-day amylin infusion.” Diabetes Jun. 2003; 52(Sup 1):A389. Abstract 1690-P.
Muff, Roman, et al., “Comparison of a CGRP and Calcitonin Receptors,” Am NY Acad Sci 1992; 657:106-116.
Rushing, P.A., “Central amylin signaling and the regulation of energy homeostasis.” Curr Pharm Des 2003; 9(10):819-825.
Rushing, P.A., et al., “Inhibition of central amylin signaling increases food intake and body adiposity in rates.” Endocrinology 2001; 142(11):5035-5038.
Rushing. P.A., et al., “A novel action in the brain to reduce body weight.” Endocrinology 2000; 141(2):850-853.
Thupari, J.N., et al., “Cronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces . . . ” Am J. Physiol Endocrinol Metab Jul. 2004; 287(1):E97-E104.
Fruin, et al., “Weight Loss Induced by Islet Amyloid Polypeptide(IAPP) is Not Fully Explained by Reduction in Food Intake,” Digestion 1997; 58(suppl 2):55.
Mack, C et al, “Sustained reduction in food intake and body weight in high fat-fed rats during 28-day amylin infusion” Poster at ADA Meeting Jun. 2003, New Orleans, Abs 1690-P.

Affiliated with

Also associated with

Rating

Methods for affecting body composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for affecting body composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for affecting body composition will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3915667